A major breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently inactivated in many types of cancer, leading https://bookmark-nation.com/story21763779/nanobodies-restore-the-p53-protein-the-promising-pathway-for-tumor-therapy